NCT00617526View on ClinicalTrials.gov

Naïve HIV POC Monotherapy Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions
HIV Infections
Interventions
DRUG

RDEA806 400 mg

DRUG

Placebo

Placebo

DRUG

RDEA806 1000 mg

DRUG

RDEA806 600 mg

DRUG

RDEA806 800 mg

Trial Locations (2)

20099

Hamburg

SW109NH

London

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY